Paper Review Records
全部论文审稿周期
16 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接
96
天
CD74 links MHC class II risk to tumor immune microenvironment remodeling across the Sjögren-to-lymphoma axis
作者
Shuyuan Liu; Meng Li; Yingying Wang; Xinhao Xia; Peiying Wang; Zhijie Ni; Qingyun Li; Qifei Teng; Wenlin Han; Jiani Liu; Xiaodong Wang; Sheng Yu; Hui Zhang; Xiangxin Meng; Fei Zhong; Hao Wang展开收起
作者单位
The Affiliated Guangzhou Hospital of TCM of Guangzhou University of Chinese Medicine, Guangzhou, 510000, Guangdong, China; Nanfang Hospital, Southern Medical University, Guangzhou, 510515, Guangdong, China; Department of Rheumatology and Immunology, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, Guangdong, China; The First School of Clinical Medicine, Southern Medical University, Guangzhou, 510515, Guangdong, China; The Second School of Clinical Medicine, Southern Medical University, Guangzhou, 510515, Guangdong, China; School of Traditional Chinese Medicine, Southern Medical University, Guangzhou, 510515, Guangdong, China; School of Basic Medical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, 510006, Guangdong, China; Department of Traditional Chinese Internal Medicine, School of Traditional Chinese Medicine, Southern Medical University, Guangzhou 510515, Guangdong, China展开收起
124
天
MF1, a novel robustic acid derivative, exerts antitumor effects in hepatocellular carcinoma
作者
Juanjuan Huang; Lijuan Teng; Tianxiu Meng; Yuqiong Liang; Yaoqi Li; Jinyan Lv展开收起
作者单位
Faculty of Chinese Medicine Science, Guangxi University of Chinese Medicine, Nanning, Guangxi Zhuang Autonomous Region, 530004, China; Krirk University, Bangkhen, Bangkok, 10220, Thailand; School of Public Health, Yale University, New Haven, CT, 06510, USA展开收起
143
天
The CARM1–YIPF2 axis drives breast cancer progression and predicts poor prognosis
作者
Xitao Gao; Shuchang Zhang; Wei Peng; Kun Xu展开收起
作者单位
Department of Breast Surgery, The Affiliated Lianyungang Hospital of Xuzhou Medical University, The First People's Hospital of Lianyungang, Lianyungang, 222002, China; Department of Breast Surgery, The Affiliated Hospital of Kangda College of Nanjing Medical University, The First People's Hospital of Lianyungang, Lianyungang, 222002, China; Department of Breast Surgery, Lianyungang Clinical College of Nanjing Medical University, The First People's Hospital of Lianyungang, Lianyungang, 222002, China; Department of Oncology, The Affiliated Cancer Hospital of Nanjing Medical University & Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research, 42 Baiziting, Nanjing, 210009, China; Department of Oncology, Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research & The Affiliated Cancer Hospital of Nanjing Medical University, 42 Baiziting, Nanjing, 210009, China展开收起
538
天
Aggressive features and immune landscape of macrotrabecular hepatocellular carcinoma
作者
Lixia Wu; Meidan Li; Xuefang Wang; Qionglan Wu; Yi Chen; Bin Wang; Lihong Chen展开收起
作者单位
Department of Pathology, Mengchao Hepatobiliary Hospital, Fujian Medical University, Fuzhou, Fujian, 350025, China; Department of Pathology and Institute of Oncology, The School of Basic Medical Sciences, Fujian Medical University, Fuzhou, Fujian, 350004, China展开收起
60
天
A renal cyst-clear cell renal cell carcinoma comorbidity analysis identifies a FOXM1-positive epithelial COL6A1-CD44 axis that remodels fibroblasts
作者
Hao Lv; Chenyi Ge; Yuming Jin; Yu Fang; Wenqiang Liu; Yan Zhang; Hanzhong Zhang; Chencan Fang; Le Qu; Xin Lu; Wentao Zhang; Nan Zhang; Aimin Jiang; Lingfeng Wu; Linhui Wang展开收起
作者单位
Department of Urology, The Fifth Clinical Medical College of Henan University of Chinese Medicine (Zhengzhou People's Hospital), Zhengzhou, Henan, China; Department of Urology, Changhai Hospital, Naval Medical University, Shanghai, China; Department of Urology, The First Naval Hospital of Southern Theater Command, Zhanjiang, China; Department of Urology, Affiliated Jinling Hospital, Medical School of Nanjing University, Nanjing, China; Department of Urology, Henan Corps Hospital of Chinese People's Armed Police Force, Zhengzhou, Henan, China; Department of Urology, The Frist Hospital of Jiaxing, Frist Affiliated Hospital of Jiaxing University, Jiaxing, Zhejiang, China展开收起
68
天
Shared inflammatory-metabolic transcriptional effects in tubulointerstitial fibrosis and clear cell renal cell carcinoma
作者
Sha Tang; Furong Li; Ling Nie; Yinghui Huang; Yiqin Wang; Jinghong Zhao; Yan Li展开收起
作者单位
Department of Nephrology, the Key Laboratory for the Prevention and Treatment of Kidney Disease of Chongqing, Chongqing Clinical Research Center of Kidney and Urology Diseases, Xinqiao Hospital, Army Medical University (Third Military Medical University), Chongqing, 400037, PR China展开收起
FAQ
Translational Oncology审稿要多久?
截至2026-11-19,CrushSCI 收录了 Translational Oncology 的 16 篇完整审稿记录。最快一篇从收稿到录用用了 60 天(A renal cyst-clear cell renal cell carcinoma comorbidity analysis identifies a FOXM1-positive epithelial COL6A1-CD44 axis that remodels fibroblasts,2026-07-27 收稿,2026-09-25 录用),最慢一篇用了 538 天;平均 123.6 天,中位数 97 天。
Expert Matching · Case Demo
把投稿要求,转成可验证的期刊方案
说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。
